Stereotactic radiosurgery (SRS) has been introduced for small-sized single and oligo-metastases in the brain. The aim of this study is to assess treatment outcome, efficacy, and prognostic variables associated with survival and intracranial recurrence.This study retrospectively reviewed 123 targets in 64 patients with non-small cell lung cancer (NSCLC) treated with SRS between January 2006 and December 2012. Treatment responses were evaluated using magnetic resonance imaging. Overall survival (OS) and intracranial progression-free survival (IPFS) were determined.The median follow-up was 13.9 months. The median OS and IPFS were 14.1 and 8.9 months, respectively. Fifty-seven patients died during the follow-up period. The 5-year local control rate was achieved in 85
作者:Yong Kyun, Won;Ja Young, Lee;Young Nam, Kang;Ji Sun, Jang;Jin-Hyoung, Kang;So-Lyoung, Jung;Soo Yoon, Sung;In Young, Jo;Hee Hyun, Park;Dong-Soo, Lee;Ji Hyun, Chang;Yun Hee, Lee;Yeon-Sil, Kim
来源:Radiation oncology journal 2015 年 33卷 3期